CeriBell (CBLL)

Profile

Full Name

CeriBell, Inc.

Ticker Symbol

CBLL

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

Indexes

Not included

Website

http://www.ceribell.com

Employees

281

Key Details

Price

$15.00(+34.53%)

Market cap

$451.69M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$65.44M(+44.71% YoY)

Annual EPS

-$3.39(-168.37% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$15.00
CBLL price is $15.00

30-Day Relative Volume

7.95
CBLL 30-day relative volume is 7.95

Price Performance

Price Most recent change

+34.53%
CBLL price was up +34.53% on Apr 11, 2025

Price YTD change

-42.04%
CBLL price is down -42.04% since January 1st

Price 1-year change

-
CBLL price 1-year change is unknown

Price 3-year change

-
CBLL price 3-year change is unknown

Price Range

Price All-time high

$32.75
CBLL price is currently -54.20% below its historical high of $32.75

Price 3-year low

$10.01
CBLL price is currently +49.85% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$451.69M
CBLL market capitalization is $451.69 million

Market cap 3-year change

-
CBLL market capitalization 3-year change is unknown

Market cap All-time high

$910.61M
CBLL market capitalization is currently -50.40% below its historical high of $910.61 million

Market cap sector rank

68.36%
CBLL market capitalization is higher than 68.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
CBLL shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
CBLL shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.63
CBLL beta is 1.63

200-day SMA

$24.13
CBLL price is currently -37.83% below its 200-day simple moving average

50-day SMA

$21.27
CBLL price is currently -29.48% below its 50-day simple moving average

RSI

38.32
CBLL 14-day relative strength index is 38.32

Volume

7.95
CBLL 30-day relative volume is 7.95

ATR

$2.23
CBLL average true range is $2.23

10-day Historical Volatility

299.30%
CBLL 10-day historical volatility is 299.30%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$65.44M
CBLL annual revenue is $65.44 million

Revenue Analysts estimate

$83.71M
CBLL annual revenue is currently -21.82% lower than the consensus analysts' forecast

Revenue 1-year change

+44.71%
CBLL annual revenue is up +44.71% year-on-year

Revenue Sector rank

51.18%
CBLL annual revenue is higher than 51.18% of companies in Healthcare sector

EPS

EPS

-$3.39
CBLL annual earnings per share is -$3.39

EPS Analysts estimate

-$1.70
CBLL annual earnings per share is currently +99.39% higher than the consensus analysts' forecast

EPS 1-year change

-168.37%
CBLL annual earnings per share is down -168.37% year-on-year

EPS Sector rank

26.09%
CBLL annual earnings per share is higher than 26.09% of companies in Healthcare sector

Profit

Gross profit

$56.75M
CBLL annual gross profit is $56.75 million

Gross margin

86.72%
CBLL annual gross profit margin is 86.72%

Operating profit

-$39.71M
CBLL annual operating income is -$39.71 million

Operating margin

-60.68%
CBLL annual operating profit margin is -60.68%

Net income

-$40.45M
CBLL annual net profit is -$40.45 million

Net margin

-61.82%
CBLL annual net profit margin is -61.82%

Expenses

Total expenses

$105.15M
CBLL annual total expenses is $105.15 million

Operating expenses

$96.46M
CBLL annual total operating expenses is $96.46 million

Cost of goods sold

$8.69M
CBLL annual cost of goods sold is $8.69 million

Selling, general & administrative expenses

$82.90M
CBLL annual SGA is $82.90 million

Depreciation and amortization

$1.14M
CBLL annual depreciation & amortization is $1.14 million

Interest expense

$1.99M
CBLL annual interest expense is $1.99 million

Income tax

$0.00
CBLL annual income tax is $0.00

EBIT & EBITDA

EBIT

-$38.46M
CBLL annual earnings before interest & taxes is -$38.46 million

EBITDA

-$37.32M
CBLL annual EBITDA is -$37.32 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$225.41M
CBLL annual total assets is $225.41 million

Non current assets

$8.14M
CBLL annual long term assets is $8.14 million

Current assets

$217.27M
CBLL annual total current assets is $217.27 million

Cash and cash equivalents

$194.37M
CBLL annual cash & cash equivalents is $194.37 million

Accounts receivable

$10.88M
CBLL annual accounts receivable is $10.88 million

Inventory

$6.94M
CBLL annual inventory is $6.94 million

Liabilities

Total liabilities

$34.25M
CBLL annual total liabilities is $34.25 million

Long term liabilities

$21.26M
CBLL annual total long term liabilities is $21.26 million

Current liabilities

$12.99M
CBLL annual total current liabilities is $12.99 million

Accounts payable

$1.14M
CBLL annual accounts payable is $1.14 million

Debt

Total debt

$21.96M
CBLL annual total debt is $21.96 million

Total debt 1-year change

+54.6%
CBLL annual total debt is up +54.6% year-on-year

Long term debt

$20.87M
CBLL annual long term debt is $20.87 million

Short term debt

$1.09M
CBLL annual short term debt is $1.09 million

Equity & Capital

Shareholders equity

$191.16M
CBLL annual stockholders equity is $191.16 million

Book value

$191.16M
CBLL annual book value is $191.16 million

Retained earnings

-$166.94M
CBLL annual retained earnings is -$166.94 million

Working capital

$204.28M
CBLL annual working capital is $204.28 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$35.04M
CBLL annual cash flow from operations is -$35.04 million

Cash from operations 1-year change

-20.18%
CBLL annual cash flow from operations is down -20.18% year-on-year

Cash from investing

-$1.60M
CBLL annual cash flow from investing activities is -$1.60 million

Cash from investing 1-year change

+9.36%
CBLL annual cash flow from investing activities is up +9.36% year-on-year

Cash from financing

$196.52M
CBLL annual cash flow from financing activities is $196.52 million

Cash from financing 1-year change

+7073.6%
CBLL annual cash flow from financing activities is up +7073.6% year-on-year

CAPEX

CAPEX

$1.34M
CBLL annual capital expenditures is $1.34 million

CAPEX 1-year change

+36.32%
CBLL annual capital expenditures is up +36.32% year-on-year

Free Cash Flow

Free cash flow

-$36.38M
CBLL annual free cash flow is -$36.38 million

Free cash flow 1-year change

-20.71%
CBLL annual free cash flow is down -20.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

86.72%
CBLL annual gross profit margin is 86.72%

Operating margin

-60.68%
CBLL annual operating profit margin is -60.68%

Net margin

-61.82%
CBLL annual net profit margin is -61.82%

ROA & ROE

ROA

-28.46%
CBLL annual return on assets is -28.46%

ROE

-102.53%
CBLL annual return on equity is -102.53%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CBLL price to earnings ratio value is unknown

PE ratio Sector rank

-
CBLL price to earnings ratio is unknown

PB Ratio

PB ratio

2.36
CBLL price to book ratio is 2.36

PB ratio Sector rank

67.6%
CBLL price to book ratio is higher than 67.6% of companies in Healthcare sector

PS Ratio

PS ratio

12.64
CBLL price to sales ratio is 12.64

PS ratio Sector rank

82.95%
CBLL price to sales ratio is higher than 82.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$279.28M
CBLL enterprise value is $279.28 million

Enterprise value Sector rank

62.76%
CBLL enterprise value is higher than 62.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-13.08
CBLL EV/EBITDA is -13.08

EV/EBITDA Sector rank

8.77%
CBLL EV/EBITDA is higher than 8.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

16.73
CBLL annual current ratio is 16.73

Quick ratio

16.19
CBLL annual quick ratio is 16.19

Leverage

Debt to equity

0.10
CBLL annual debt to equity ratio is 0.10

Interest coverage ratio

-19.31
CBLL annual interest coverage ratio is -19.31

Risk & Stability

Piotroski F-Score

-
CBLL piotroski f-score value is unknown

Altman Z-Score

7.69
CBLL altman z-score is 7.69

Analyst ratings

Recent major analysts updates

Apr 4, 25 Ladenburg Thalmann
Buy
Feb 26, 25 Canaccord Genuity
Buy
Dec 9, 24 TD Cowen
Buy
Dec 9, 24 Canaccord Genuity
Buy
Nov 13, 24 Canaccord Genuity
Buy
Nov 5, 24 William Blair
Outperform
Nov 5, 24 TD Cowen
Buy
Nov 5, 24 JP Morgan
Overweight
Nov 5, 24 Canaccord Genuity
Buy
Nov 5, 24 B of A Securities
Buy

Institutional Ownership

Similar stocks

CGEM logo
Cullinan Oncology (CGEM)
CRMD logo
CorMedix (CRMD)
MDRX logo
Veradigm (MDRX)
Niagen Bioscience (NAGE)
CDXC logo
ChromaDex (CDXC)
SAGE logo
Sage Therapeutics (SAGE)
BCYC logo
Bicycle Therapeutics (BCYC)
SVA logo
Sinovac Biotech (SVA)
KURA logo
Kura Oncology (KURA)
  • What is the ticker symbol for CeriBell?
  • Does CeriBell pay dividends?
  • What sector is CeriBell in?
  • What industry is CeriBell in?
  • What country is CeriBell based in?
  • Is CeriBell in the S&P 500?
  • Is CeriBell in the NASDAQ 100?
  • Is CeriBell in the Dow Jones?
  • When was CeriBell's last earnings report?
  • When does CeriBell report earnings?
  • Should I buy CeriBell stock now?

What is the ticker symbol for CeriBell?

The ticker symbol for CeriBell is NASDAQ:CBLL

Does CeriBell pay dividends?

No, CeriBell does not pay dividends

What sector is CeriBell in?

CeriBell is in the Healthcare sector

What industry is CeriBell in?

CeriBell is in the Medical Devices industry

What country is CeriBell based in?

CeriBell is headquartered in United States

Is CeriBell in the S&P 500?

No, CeriBell is not included in the S&P 500 index

Is CeriBell in the NASDAQ 100?

No, CeriBell is not included in the NASDAQ 100 index

Is CeriBell in the Dow Jones?

No, CeriBell is not included in the Dow Jones index

When was CeriBell's last earnings report?

CeriBell's most recent earnings report was on Feb 25, 2025

When does CeriBell report earnings?

The next expected earnings date for CeriBell is May 30, 2025

Should I buy CeriBell stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page